- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04905225
The Gender Specific Effect on the Results of Ascending Aortic Replacement
The Gender Specific Effect on the Results of Ascending Aortic Replacement in Small Ascending Aortic Aneurysm
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Description of the procedures:
All surgical procedures will be performed via median sternotomy. During the aortic arch anastomosis, continuous, unilateral SACP using innominate artery will be employed. Unilateral SACP may be converted to bilateral ACP at the surgeon's discretion if adequate cerebral flows are not achieved or if there are concerns with cerebral oximetry measurements.
Once on CPB, the patient will be cooled to a nasopharyngeal (NP) temperature of either 26-32 °C. Rectal temperature with be monitored as an additional temperature sites. Unilateral SACP will only be initiated once the target temperature has been reached. SACP via the innominate artery will be commenced with target flows of 8-10 ml/kg/min and perfusion pressure of 60-80 mmHg. Perfusion adequacy will be evaluated using measurement of blood pressure in both radial arteries and cerebral oximetry using near-infrared spectroscopy (NIRS).
After completion of the aortic hemiarch replacement, CPB will be resumed and the patient re-warmed to 36 °C prior to coming off CPB, with a = 1 °C temperature difference between temperature monitoring sites (NP and rectal).
Intraoperative information will be collected from the anesthetic record, surgical notes and perfusion records. Intraoperative data collection will include total operative time, CPB time, cross-clamp time, hypothermic cardiac arrest time, uSACP time, lowest nasopharyngeal and rectal temperature, arterial pressure in both radial arteries, perfusion rate and perfusion pressure during both of CPB and unilateral SACP, lowest hemoglobin concentration (g/L) and hematocrit (%), acid-base indices, intraoperative red blood cell transfusion (units), highest dose/agent used for intraoperative inotrope or vasopressor support. Also during the surgery will be performed NIRS and BIS-monitoring(bispectral index).
Postoperative data will include valuation of following indicators: mortality (hospital mortality and death from any cause); neurological injury (TIA, stroke, delirium), MRI and CT-scan only in event of postoperative stroke; acute kidney injury (creatinine level prior and 1, 2, 4 postoperative day (POD), renal replacement therapy (dialysis); time of mechanical ventilation; re-exploration for bleeding, tamponade or other reasons; postoperative transfusion (packed red blood cells, platelets, fresh frozen platelets, cryoprecipitate); postoperative myocardial infarction (electrocardiogram and troponins); length of stay (intensive care unit and total hospital days).
Follow-up information will be collected using direct or phone contact with patients, relatives, or physicians.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Tomsk, Russian Federation, 634012
- Tomsk NRMC
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with small ascending aortic aneurysm (5.0-5.5 cm)
- Elective procedure
- Able to provide written informed consent
Exclusion Criteria:
- Surgery for acute aortic dissection or emergent operations
- Refusal of surgical treatment
- Oncological disease (high degrees)
- Multiple organ failure
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Ascending aortic replacement
Ascending aortic replacement in ascending aortic aneurysm in men and women
|
Surgical access will be performed through a median sternotomy.
Ascending aortic repair is performed under conditions of cardiopulmonary bypass (CPB) and MHCA with unilateral ACP via innominate artery with a flow rate of 8-10 ml/kg/min and perfusion pressure of 60-80 mmHg.
Once CPB is instituted, the aortic cross-clamp is applied, and the heart is arrested with antegrade cardioplegia.
Hemiarch replacement involves resection lesser curve of the aortic arch from the base of the innominate artery (Zone 0) to a point immediately distal to the nadir of the lesser curvature (Zone 3 or Zone 2 if the left subclavian artery was too far).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Operative mortality
Time Frame: During the first 30 days after the procedure
|
Operative mortality (%) as assessed by data linkage to medical records Comparison of men vs women in aortic hemiarch surgery with respect to the incidence of death
|
During the first 30 days after the procedure
|
All-cause mortality
Time Frame: Up to 5 years
|
all-cause mortality as assessed by data linkage to medical records or or phone contact with relatives or physicians
|
Up to 5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perioperative Myocardial Infarction
Time Frame: During the first 30 days after the procedure (assessed by daily serum assay and ECG in the ICU and every 5 days after discharge from ICU. )
|
Incidence of the myocardial infarction (%) is assessed by complex evaluation based on the ECG and echocardiographic changes as well as increase of the troponin level using serum assay
|
During the first 30 days after the procedure (assessed by daily serum assay and ECG in the ICU and every 5 days after discharge from ICU. )
|
Rates of re-exploration for bleeding
Time Frame: During the first 3 days after the procedure
|
Percentage of patients requiring re-exploration for bleeding.
|
During the first 3 days after the procedure
|
Respiratory failure
Time Frame: During the first 30 days after the procedure
|
Percentage of patients requiring prolonged lung ventilation (> 72 hours) or tracheostomy
|
During the first 30 days after the procedure
|
The duration of a patient's stay in the intensive care unit and on the hospital ward
Time Frame: Up to 90 days after surgery
|
The duration of a patient's stay in the intensive care unit and on the hospital ward
|
Up to 90 days after surgery
|
Incidence of Acute Kidney Injury (AKI)
Time Frame: During the first 30 days after the procedure
|
Percentage of patients requiring renal replacement therapy (i.e.
haemodialysis or haemofiltration
|
During the first 30 days after the procedure
|
Composite of neurologic injury
Time Frame: During the first 30 days after the procedure
|
Percentage of patients with neurological complications is assessed.
Single assessment by CT or MRI.
More often if necessary.
|
During the first 30 days after the procedure
|
Collaborators and Investigators
Investigators
- Study Director: Boris N Kozlov, Dr, TOMSK NRMC CARDIOLOGY RESEARCH INSTITUTE
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Tomsk NRMC CRI
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ascending Aortic Aneurysm
-
Ottawa Heart Institute Research CorporationUniversity of CalgaryRecruitingAscending Aorta Aneurysm | Ascending Aortic Aneurysm EnlargementUnited States, Canada
-
University of North Carolina, Chapel HillCook Group Incorporated; UNC HospitalsEnrolling by invitationAortic Aneurysm, Abdominal | Aortic Arch Aneurysm | Ascending Aorta AneurysmUnited States
-
Centre Hospitalier Universitaire DijonRecruitingPatient With Ascending Aortic Aneurysm With Surgical Indication for ReplacementFrance
-
Tomsk National Research Medical Center of the Russian...CompletedAscending Aortic AneurysmRussian Federation
-
China National Center for Cardiovascular DiseasesActive, not recruitingAortic Stenosis | Ascending Aortic DilatationChina
-
University of Sao Paulo General HospitalInCor Heart Institute; 3-D Matrix Medical TechnologyUnknownAscending Aorta Abnormality | Ascending Aortic Dissection | Ascending Aorta AneurysmBrazil
-
Matthew EagletonMassachusetts General HospitalEnrolling by invitationAortic Dissection | Ascending Aortic Dissection | Thoracoabdominal Aortic Aneurysm | Thoracic Aortic Aneurysms | Dissecting, Aneurysm | Ascending Aorta Aneurysm | Aortic Arch; Aneurysm, Dissecting | Renal Artery Aneurysm | Superior Mesenteric Artery AneurysmUnited States
-
Chinese Medical AssociationChanghai HospitalUnknown
-
Tomsk National Research Medical Center of the Russian...RecruitingAscending Aorta Aneurysm | Dilation of the Ascending AortaRussian Federation
-
Meshalkin Research Institute of Pathology of CirculationUnknownAortic Insufficiency | Ascending Aorta AneurismRussian Federation
Clinical Trials on Ascending aortic replacement
-
Nicolaus Copernicus UniversityMaastricht University Medical Center; Centre of Postgraduate Medical Education and other collaboratorsRecruiting
-
Centre Cardiologique du NordUniversita degli Studi di Genova; Henri Mondor University Hospital; Pitié-Salpêtrière...Enrolling by invitationAortic Valve Insufficiency | Aortic Diseases | Ascending Aortic Dissection | Aortic Arch | Aortic Root Dissection | Aortic Root Dilatation | Type A Aortic DissectionFrance
-
Michele De BonisCompletedBicuspid Aortic Valve | Ascending Aorta AneurysmItaly
-
OptimapharmEdwards LifesciencesActive, not recruitingAortic Valve Stenosis | Heart Valve DiseasesUnited Kingdom, Italy, Germany, France, Austria, Switzerland, Finland, Czechia, Belgium, Netherlands, Cyprus, Ireland
-
Karolinska University HospitalKarolinska InstitutetCompletedAortic Valve Stenosis | Heart Valve DiseasesSweden
-
St. Antonius HospitalCompletedQuality of Life | Aortic Valve Stenosis | Limited Access Aortic Valve ReplacementNetherlands
-
Centre Cardiologique du NordUniversita degli Studi di Genova; Campus Bio-Medico University; Henri Mondor... and other collaboratorsEnrolling by invitation
-
Cliniques universitaires Saint-Luc- Université...Unknown
-
Karolinska University HospitalKarolinska InstitutetCompletedAortic Valve Stenosis | Heart Valve DiseasesSweden
-
Assistance Publique - Hôpitaux de ParisUnknownAortic Valve Stenosis | Aortic Valve SurgeryFrance